Companies /Healthcare
United Therapeutics Corp
NASDAQ: UTHR Drug Manufacturers - Specialty & Generic
$540.03
▼ $3.37 (−0.62%) today
Markets closed · 12:26am ET

United Therapeutics (UTHR) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
67%
EPS beat rate
+1.11%
Avg. EPS surprise
Consecutive EPS beats
UTHR vs Market · 30-day return after each reportUTHRS&P 500
−10%−5%0%+5%+7.4%+6.9%Q1 25+8.1%+1.7%Q2 25+5.4%−1.0%Q3 25−2.3%−8.5%Q4 25−8.7%+0.7%Q1 26−6.1%+0.1%Q2 26
−10%−5%0%+5%Q1 25Q3 25Q1 26
UTHR EPS Trend · estimate vs actualEstimateActual
$0$3$6$6.28$6.63Q1 25$6.92$6.41Q2 25$6.96$7.16Q3 25$6.76$7.70Q4 25$6.86$5.82Q1 26$6.82$7.27Q2 26
$0$3$6Q1 25Q3 25Q1 26
UTHR Revenue Trend · estimate vs actualEstimateActual
$0$300.0M$600.0M$726.4M$794.4MQ1 25$803.6M$798.6MQ2 25$812.9M$799.5MQ3 25$811.4M$790.2MQ4 25$797.4M$781.5MQ1 26
$0$300.0M$600.0MQ1 25Q2 25Q3 25Q4 25Q1 26

How Often Does United Therapeutics Beat Earnings Estimates?

United Therapeutics beat EPS estimates in 4 of its last 6 reported quarters.

UTHR quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $7.27 est. $6.82 +6.60% $783.3M —
Q1 2026 $5.82 est. $6.86 −15.13% $781.5M est. $797.4M −1.99%
Q4 2025 $7.70 est. $6.76 +13.99% $790.2M est. $811.4M −2.61%
Q3 2025 $7.16 est. $6.96 +2.86% $799.5M est. $812.9M −1.65%
Q2 2025 $6.41 est. $6.92 −7.31% $798.6M est. $803.6M −0.63%
Q1 2025 $6.63 est. $6.28 +5.62% $794.4M est. $726.4M +9.37%

Figures from SEC filings and company reports. Not investment advice.